179 related articles for article (PubMed ID: 38335381)
41. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma.
Qin Y; Zhang Y; Tang Q; Jin L; Chen Y
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):138-148. PubMed ID: 28069586
[TBL] [Abstract][Full Text] [Related]
42.
Zhang R; Deng Y; Lv Q; Xing Q; Pan Y; Liang J; Jiang M; Wei Y; Shi D; Xie B; Yang S
Cell Reprogram; 2020 Feb; 22(1):22-29. PubMed ID: 32011919
[TBL] [Abstract][Full Text] [Related]
43. Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.
Ma R; Guan X; Teng N; Du Y; Ou S; Li X
BMC Med Genomics; 2023 Oct; 16(1):254. PubMed ID: 37864213
[TBL] [Abstract][Full Text] [Related]
44. Squalene epoxidase expression is associated with breast tumor progression and with a poor prognosis in breast cancer.
Kim NI; Park MH; Kweon SS; Cho N; Lee JS
Oncol Lett; 2021 Apr; 21(4):259. PubMed ID: 33664822
[TBL] [Abstract][Full Text] [Related]
45. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway.
Xu R; Song J; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
Cell Death Dis; 2023 Aug; 14(8):497. PubMed ID: 37542052
[TBL] [Abstract][Full Text] [Related]
46. p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer.
Fischer M
Int J Biol Sci; 2023; 19(15):4831-4832. PubMed ID: 37781510
[TBL] [Abstract][Full Text] [Related]
47. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma.
Wang X; Huang Y; Li S; Zhang H
Front Immunol; 2022; 13():1027154. PubMed ID: 36275754
[TBL] [Abstract][Full Text] [Related]
48. Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis.
Tan JME; Cook ECL; van den Berg M; Scheij S; Zelcer N; Loregger A
Atherosclerosis; 2019 Feb; 281():137-142. PubMed ID: 30658189
[TBL] [Abstract][Full Text] [Related]
49. Squalene monooxygenase facilitates bladder cancer development in part by regulating PCNA.
Zhu C; Fang X; Liu X; Jiang C; Ren W; Huang W; Jiang Y; Wang D
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119681. PubMed ID: 38280406
[TBL] [Abstract][Full Text] [Related]
50. The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation.
Polycarpou-Schwarz M; Groß M; Mestdagh P; Schott J; Grund SE; Hildenbrand C; Rom J; Aulmann S; Sinn HP; Vandesompele J; Diederichs S
Oncogene; 2018 Aug; 37(34):4750-4768. PubMed ID: 29765154
[TBL] [Abstract][Full Text] [Related]
51. Estrogen Abolishes the Repression Role of gga-miR-221-5p Targeting
Zhang DD; Wang DD; Wang Z; Wang YB; Li GX; Sun GR; Tian YD; Han RL; Li ZJ; Jiang RR; Liu XJ; Kang XT; Li H
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120850
[TBL] [Abstract][Full Text] [Related]
52. The shape of human squalene epoxidase expands the arsenal against cancer.
Brown AJ; Chua NK; Yan N
Nat Commun; 2019 Feb; 10(1):888. PubMed ID: 30792392
[TBL] [Abstract][Full Text] [Related]
53. The MARCH6-SQLE Axis Controls Endothelial Cholesterol Homeostasis and Angiogenic Sprouting.
Tan JME; van der Stoel MM; van den Berg M; van Loon NM; Moeton M; Scholl E; van der Wel NN; Kovačević I; Hordijk PL; Loregger A; Huveneers S; Zelcer N
Cell Rep; 2020 Aug; 32(5):107944. PubMed ID: 32755570
[TBL] [Abstract][Full Text] [Related]
54. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
55. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
56. Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma.
Li G; Chen L; Bai H; Zhang L; Wang J; Li W
Precis Clin Med; 2024 Jun; 7(2):pbae011. PubMed ID: 38779359
[TBL] [Abstract][Full Text] [Related]
57. Localization of the squalene epoxidase gene (SQLE) to human chromosome region 8q24.1.
Nagai M; Sakakibara J; Wakui K; Fukushima Y; Igarashi S; Tsuji S; Arakawa M; Ono T
Genomics; 1997 Aug; 44(1):141-3. PubMed ID: 9286711
[TBL] [Abstract][Full Text] [Related]
58. SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro.
Zhao F; Huang Y; Zhang Y; Li X; Chen K; Long Y; Li F; Ma X
Mol Biol Rep; 2022 Jul; 49(7):6613-6621. PubMed ID: 35552960
[TBL] [Abstract][Full Text] [Related]
59. Targeting Squalene Epoxidase Confers Metabolic Vulnerability and Overcomes Chemoresistance in HNSCC.
Zhao X; Guo B; Sun W; Yu J; Cui L
Adv Sci (Weinh); 2023 Sep; 10(27):e2206878. PubMed ID: 37490552
[TBL] [Abstract][Full Text] [Related]
60. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
